Castle Biosciences (CSTL) Return on Capital Employed (2019 - 2026)
Castle Biosciences (CSTL) posted Return on Capital Employed of 6.47% for Q1 2026, up 24.12% sequentially from 8.53% in Q4 2025, and down 359.0% YoY from 2.5% in Q1 2025.
Castle Biosciences (CSTL) Return on Capital Employed (2019 - 2026) Analysis & Trends
Castle Biosciences (CSTL) has 8 years of Return on Capital Employed data on file, last reported at 6.47% in Q1 2026.
- Quarterly Return on Capital Employed fell 359.0% year-over-year to 6.47% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6.47% (down 359.0% YoY) and the FY2025 annual result came in at 8.8%, down 1076.0% from the prior year.
- Return on Capital Employed climbed to 6.47% in Q1 2026 per CSTL's latest filing, from 8.53% in the prior quarter.
- The five-year high for Return on Capital Employed was 1.83% in Q4 2024, with the low at 24.73% in Q2 2023.
- Average Return on Capital Employed over 5 years is 10.89%, with a median of 9.89% recorded in 2024.
- Year-over-year, Return on Capital Employed tumbled 1175 bps in 2022 and soared 2136 bps in 2024.
- Castle Biosciences' Return on Capital Employed stood at 17.49% in 2022, then rose by 2 bps to 17.12% in 2023, then surged by 111 bps to 1.83% in 2024, then slumped by 566 bps to 8.53% in 2025, then gained by 24 bps to 6.47% in 2026.
- Business Quant data shows CSTL's Return on Capital Employed at 6.47% in Q1 2026, 8.53% in Q4 2025, and 7.01% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 4.82% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 8.12% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 6.26% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 67.98% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -3.63% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 14.57% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 10.24% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 16.90% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 45.73% |
| 10 | Castle Biosciences | 738.56 Mn | 476.84 Mn | 63.15 Mn | -6.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.47% |
| Dec 31, 2025 | -8.53% |
| Sep 30, 2025 | -7.01% |
| Jun 30, 2025 | -4.88% |
| Mar 31, 2025 | -2.88% |
| Dec 31, 2024 | 1.83% |
| Sep 30, 2024 | -0.23% |
| Jun 30, 2024 | -3.64% |
| Mar 31, 2024 | -9.89% |
| Dec 31, 2023 | -17.12% |
| Sep 30, 2023 | -21.59% |
| Jun 30, 2023 | -24.73% |
| Mar 31, 2023 | -19.62% |
| Dec 31, 2022 | -17.49% |
| Sep 30, 2022 | -15.30% |
| Jun 30, 2022 | -13.09% |
| Mar 31, 2022 | -14.57% |
| Dec 31, 2021 | -9.47% |
| Sep 30, 2021 | -6.76% |
| Jun 30, 2021 | -4.79% |